{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:40:42Z","timestamp":1794555642911,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4902,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1046\/j.1523-1747.2002.01808.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:03:25Z","timestamp":1047449005000},"page":"160-165","source":"Crossref","is-referenced-by-count":4,"title":["A Highly Decreased Binding of Cyclic Adenosine Monophosphate to Protein Kinase A in Erythrocyte Membranes is Specific for Active Psoriasis"],"prefix":"10.1016","volume":"119","author":[{"given":"Rudolf E.","family":"Schopf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Langendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman E.","family":"Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Benes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"F\u00e4rber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0010","first-page":"74","article-title":"Epidermal cyclic AMP is not decreased in psoriasis lesions","volume":"74","author":"Adachi","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1523-1747.2001.01283.x","article-title":"The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris","volume":"116","author":"Alessandrini","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0020","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1073\/pnas.83.14.5272","article-title":"Deficiency of cyclic AMP-dependent protein kinases in human psoriasis","volume":"83","author":"Brion","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0025","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trial","volume":"357","author":"Chaudhari","year":"2001","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0030","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0140-6736(86)91824-6","article-title":"Beta-blockers induce class II MHC antigens on psoriatic keratinocytes","volume":"i","author":"Czernielewski","year":"1986","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0035","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1523-1747.2000.00962.x","article-title":"Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis","volume":"114","author":"Dimon-Gadal","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0040","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1073\/pnas.93.19.10217","article-title":"Ethanol causes translocation of cAMP-dependent protein kinase catalytic subunit to the nucleus","volume":"93","author":"Dohrman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0045","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1073\/pnas.75.12.5926","article-title":"Compartmentalization of cyclic AMP-dependent protein kinases in human erythrocytes","volume":"75","author":"Dreyfuss","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2133.1990.tb14724.x","article-title":"Beta-adrenergic stimulation of cyclic AMP is defective in cultured dermal fibroblasts of psoriatic subjects","volume":"122","author":"Eedy","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis\u2014oral therapy with a new retinoid","volume":"157","author":"Fredricksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199503023320907","article-title":"Treatment of psoriasis","volume":"332","author":"Greaves","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0070","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.4049\/jimmunol.167.7.4026","article-title":"Inflammatory cytokines regulate functions and expression of adenosine A (2A) receptors in human monocytic THP-1 cells","volume":"167","author":"Khoa","year":"2001","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2133.1983.tb03542.x","article-title":"Erythrocyte membrane phosphorylation in untreated and in etretinate-treated psoriatic patients","volume":"109","author":"Kumar","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1523-1747.1998.00149.x","article-title":"Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp 120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts","volume":"110","author":"Liapi","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00417149","article-title":"Penetration kinetics of dehydroepiandrosterone through the erythrocyte membrane","volume":"270","author":"Morsches","year":"1981","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1523-1747.ep12534532","article-title":"Reversal of beta-agonist-induced refractoriness in skin by tetracaine and mepacrine","volume":"80","author":"Nemoto","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0095","first-page":"129","article-title":"Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis","volume":"138","author":"Nickoloff","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0100","first-page":"808","volume":"54","author":"Partsch","year":"1979"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1523-1747.ep12580448","article-title":"Retinoid treatment of human psoriatic fibroblasts induces an increase in cyclic AMP-dependent protein kinase activity","volume":"89","author":"Raynaud","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0110","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(89)92748-7","article-title":"A cAMP abnormality in psoriasis","volume":"i","author":"Raynaud","year":"1989","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/1523-1747.ep12354923","article-title":"Rapid effect of treatment of psoriatic erythrocytes with the synthetic retinoid acitretin to increase 8-azido cyclic AMP binding to the RI regulatory subunit","volume":"100","author":"Raynaud","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0891-5849(96)00353-X","article-title":"Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis","volume":"22","author":"Raynaud","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/1523-1747.ep12274844","article-title":"Stimulus-dependent increased generation oxygen intermediates in monocytes and polymorphonuclear leukocytes in psoriasis","volume":"84","author":"Schopf","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00418169","article-title":"Augmented glucose-6-phosphate dehydrogenase activity and normal penetration and metabolism of dehydroepiandrosterone in mononuclear leukocytes in psoriasis","volume":"278","author":"Schopf","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00375799","article-title":"Etretinate of cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis","volume":"284","author":"Schopf","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0140","unstructured":"Schopf RE, Aust H, Knop J: Treatment of psoriasis with the mouse-human chimeric monoclonal antibody against TNF-alpha, Infliximab. J Am Acad Dermatol, in press"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2362.1988.tb01164.x","article-title":"Red blood cell sodium and potassium fluxes in psoriatic patients","volume":"18","author":"Semplicini","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0150","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/1523-1747.ep12349055","article-title":"Antioxidant enzymes in psoriatic fibroblasts and erythrocytes","volume":"106","author":"Th\u00e9rond","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0155","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/jcb.240570409","article-title":"Post-translational abnormality of the type II cyclic AMP-dependent protein kinase in psoriasis: modulation by retinoic acid","volume":"57","author":"Tournier","year":"1995","journal-title":"J Cell Biochem"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1097-4652(199605)167:2<196::AID-JCP2>3.0.CO;2-K","article-title":"Retinoylation of the type II cAMP-binding regulatory subunit of cAMP","volume":"167","author":"Tournier","year":"1996","journal-title":"J Cell Physiol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0165","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archderm.1971.04000220010003","article-title":"Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade","volume":"104","author":"Voorhees","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0170","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archderm.1972.01620080025008","article-title":"Decreased cyclic AMP in the epidermis of lesions of psoriasis","volume":"105","author":"Voorhees","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/1523-1747.ep12625885","article-title":"The cyclic AMP system in normal and psoriatic epidermis","volume":"59","author":"Voorhees","year":"1972","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/1523-1747.ep12598125","article-title":"Cyclic AMP, cyclic GMP, and glucocorticoids as potential metabolic regulators of epidermal proliferation and differentiation","volume":"65","author":"Voorhees","year":"1975","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0185","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1016\/S0021-9258(17)39985-4","article-title":"Identification, characterization, and quantitative measurement of cyclic AMP receptor proteins in cytosol of various tissues using a photoaffinity ligand","volume":"252","author":"Walter","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1747.2002.01808.x_bb0190","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2133.1975.tb03140.x","article-title":"On the lack of response to catecholamine stimulation by the adenyl cyclase system in psoriatic lesions","volume":"92","author":"Yoshikawa","year":"1975","journal-title":"Br J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15417178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15417178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T22:20:54Z","timestamp":1622240454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15417178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S0022202X15417178"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2002.01808.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}